Selective AKT1 inhibitor A-674563 strengthened cancer cell apoptosis compared to pan-Akt inhibitor MK-2206, which demonstrated that targeting the AKT1 isoform might be more effective than suppressing the Akt isoforms (21). Here, AKT1 is linked to cancer.